REVIEW: ANIMAL SERUM REPLACEMENT IN MESENCHYMAL STEM CELLS CULTURE
Main Article Content
Abstract
Mesenchymal stem cells (MSCs) are being used in clinical applications and must comply with Good Manufacturing Practices (GMP) standards and The National Agency of Drug and Food Control (NA-DFC)) regulations. MSCs cultured using a culture medium and added with several supplements like animal serums. However, animal serums can be a source of virus transmission. Therefore, it is necessary to substitute supplements for the animal serum that are safe to use in cell therapy using MSCs. The paper discusses substituting animal serum MSCs culture. This paper is a literature review through a literature search in scientific journals and research reports that explains the various studies on free serum in the culture of MSCs. It can be concluded that human platelet lysate (hPL), human platelet-rich plasma (hPRP), human serum (hS), human umbilical cord serum/plasma (hUCS/P), or human plasma-derived supplement for cell culture medium (SCC) can be used as substitutes for animal serum in MSCs culture.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
a). Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Attribution-NonCommercial-ShareAlike 4.0 International that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
b). Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
c). Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
References
Ahrari I, Zarandi NP, Maharlooei MK, Monabati A, Attari A, Ahrari S (2013) Adipose tissue derived multipotent mesenchymal stromal cells can be isolated using serum-free media. Iran Red Crescent Med J 15:324–9. doi: 10.5812/ircmj.4506
Alberts B, Bray D, Hopkin K, Johnson A, Lewis J, Raff M, Roberts K, Walter P (2014) Essential Cell Biology, Fourth Edition. Garland Science, New York
Aldahmash A, Haack-Sørensen M, Al-Nbaheen M, Harkness L, Abdallah BM, Kassem M (2011) Human serum is as efficient as fetal bovine serum in supporting proliferation and differentiation of human multipotent stromal (mesenchymal) stem cells in vitro and in vivo. Stem Cell Rev Rep 7:860–868. doi: 10.1007/s12015-011-9274-2
Alishahi M, Anbiyaiee A, Farzaneh M, Khoshnam SE (2020) Human mesenchymal stem cells for spinal cord injury. Curr Stem Cell Res Ther 15:340–348. doi: 10.2174/1574888X15666200316164051
Al-Saqi SH, Saliem M, Asikainen S, Quezada HC, Ekblad A, Hovatta O, Le Blanc K, Jonasson AF, Gotherstrom C (2014) Defined serum-free media for in vitro expansion of adipose-derived mesenchymal stem cells. Cytotherapy 16:915–926. doi: 10.1016/j.jcyt.2014.02.006
Amin N, Tan X, Ren Q, Zhu N, Botchway BOA, Hu Z, Fang M (2019) Recent advances of induced pluripotent stem cells application in neurodegenerative diseases. Prog Neuropsychopharmacol Biol Psychiatry 95:109674. doi: 10.1016/j.pnpbp.2019.109674
Baghban R, Farajnia S, Rajabibazl M, Ghasemi Y, Mafi AA, Hoseinpoor R, Rahbarnia L, Aria M (2019) Yeast expression systems: Overview and recent advances. Mol Biotechnol 61:365–384. doi: 10.1007/s12033-019-00164-8
Batsali AK, Kastrinaki M-C, Papadaki HA, Pontikoglou C (2013) Mesenchymal stem cells derived from Wharton’s Jelly of the umbilical cord: Biological properties and emerging clinical applications. Curr Stem Cell Res Ther 8:144–155. doi: 10.2174/1574888x11308020005
Blázquez-Prunera A, Díez JM, Gajardo R, Grancha S (2017) Human mesenchymal stem cells maintain their phenotype, multipotentiality, and genetic stability when cultured using a defined xeno-free human plasma fraction. Stem Cell Res Ther 8:103. doi: 10.1186/s13287-017-0552-z
Bui HTH, Nguyen LT, Than UTT (2021) Influences of xeno-free media on mesenchymal stem cell expansion for clinical application. Tissue Eng Regen Med 18:15–23. doi: 10.1007/s13770-020-00306-z
Burnouf T, Strunk D, Koh MBC, Schallmoser K (2016) Human platelet lysate: Replacing fetal bovine serum as a gold standard for human cell propagation? Biomaterials 76:371–387. doi: 10.1016/j.biomaterials.2015.10.065
Cardoso TC, Ferrari HF, Garcia AF, Novais JB, Silva-frade C, Ferrarezi MC, Andrade AL, Gameiro R (2012) Isolation and characterization of Wharton’s jelly-derived multipotent mesenchymal stromal cells obtained from bovine umbilical cord and maintained in a defined serum-free three-dimensional system. BMC Biotechnol 12:18. doi: 10.1186/1472-6750-12-18
Castells-Sala C, Martorell J, Balcells M (2017) A human plasma derived supplement preserves function of human vascular cells in absence of fetal bovine serum. Cell Biosci 7:41. doi: 10.1186/s13578-017-0164-4
Chang C, Chang K, Tsai S, Chang H, Lin C (2014) Neurogenic differentiation of dental pulp stem cells to neuron-like cells in dopaminergic and motor neuronal inductive media. J Formos Med Assoc 113:956–965. doi: 10.1016/j.jfma.2014.09.003
Chase LG, Lakshmipathy U, Solchaga LA, Rao MS, Vemuri MC (2010) A novel serum-free medium for the expansion of human mesenchymal stem cells. Stem Cell Res Ther 1:8. doi: 10.1186/scrt8
Cheever M, Versteegen R, Master A (2017) A method for differentiating fetal bovine serum from newborn calf serum. Bioprocess J 16:1–6. doi: 10.12665/j16oa.cheever
Chen PR, Redel BK, Spate LD, Ji T, Salazar SR, Prather RS (2018) Glutamine supplementation enhances development of in vitro-produced porcine embryos and increases leucine consumption from the medium. Biol Reprod 99:938–948. doi: 10.1093/biolre/ioy129
Chevallier N, Anagnostou F, Zilber S, Bodivit G, Maurin S, Barrault A, Bierling P, Hernigou P, Layrolle P, Rouard H (2010) Osteoblastic differentiation of human mesenchymal stem cells with platelet lysate. Biomaterials 31:270–278. doi: 10.1016/j.biomaterials.2009.09.043
Cowper M, Frazier T, Wu X, Curley JL, Ma MH, Mohiuddin OA, Dietrich M, McCarthy M, Bukowska J, Gimble JM (2019) Human platelet lysate as a functional substitute for fetal bovine serum in the culture of human adipose derived stromal/stem cells. Cells 8:724. doi: 10.3390/cells8070724
Devireddy LR, Myers M, Screven R, Liu Z, Boxer L (2019) A serum-free medium formulation efficiently supports isolation and propagation of canine adipose-derived mesenchymal stem/stromal cells. PLoS One 14:e0210250. doi: 10.1371/journal.pone.0210250
Díez JM, Bauman E, Gajardo R, Jorquera JI (2015) Culture of human mesenchymal stem cells using a candidate pharmaceutical grade xeno-free cell culture supplement derived from industrial human plasma pools. Stem Cell Res Ther 6:28. doi: 10.1186/s13287-015-0016-2
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach, I Marini FC, Krause DS, Deans RJ, Keating A, Prockop DJ, Horwitz EM (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315–317. doi: 10.1080/14653240600855905
Fekete N, Gadelorge M, Furst D, Maurer C, Dausend J, Fleury-Cappellesso S, Mailnder V, Lotfi R, Ignatius A, Sensebé L, Bourin P, Schrezenmeier H, Rojewski MT (2012) Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: Production process, content and identification of active components. Cytotherapy 14:540–554. doi: 10.3109/14653249.2012.655420
Fong D, Duceppe N, Hoemann CD (2017) Mesenchymal stem cell detachment with trace trypsin is superior to EDTA for in vitro chemotaxis and adhesion assays. Biochem Biophys Res Commun 484:656–661. doi: 10.1016/j.bbrc.2017.01.171
Friedenstein A, Chailakhyan R, Latsinik N, Panasyuk A, Keiliss-Borok I (1974) Stromal cells responsible for transferring the microenvironment of the hematopoietic tissues. Cloning in vitro and retransplantation in vivo.Transplantation 17:331–340. doi: 10.1097/00007890-197404000-00001
Guiotto M, Raffoul W, Hart AM, Riehle MO, di Summa PG (2020) Human platelet lysate to substitute fetal bovine serum in hMSC expansion for translational applications: A systematic review. J Transl Med 18:351. doi: 10.1186/s12967-020-02489-4
Halim D, Murti H, Sandra F, Boediono A, Djuwantono T, Setiawan B (2010) Stem Cell – Dasar Teori & Aplikasi Klinis. Penerbit Erlangga, Jakarta
Jagusic M, Forcic D, Brgles M, Kutle L, Santak M, Jergovic M, Kotarski L, Bendelja K, Halassy B (2016) Stability of minimum essential medium functionality despite L-glutamine decomposition. Cytotechnology 68:1171–1183. doi: 10.1007/s10616-015-9875-8
Jonsdottir-Buch SM, Lieder R, Sigurjonsson OE (2013) Platelet lysates produced from expired platelet concentrates support growth and osteogenic differentiation of mesenchymal stem cells. PLoS One 8:e68984. doi: 10.1371/journal.pone.0068984
Jung S, Panchalingam KM, Rosenberg L, Behie LA (2012) Ex vivo expansion of human mesenchymal stem cells in defined serum-free media. Stem Cells Int 2012:123030. doi: 10.1155/2012/123030
Krishnan A, Woodard SL (2014) TrypZeanTM: An animal-free alternative to bovine trypsin. Pp 43-63. In: Howard J, Hood E (Eds) Commercial Plant-Produced Recombinant Protein Products, Biotechnology in Agriculture and Forestry, Vol 68th. Springer, Berlin. doi: 10.1007/978-3-662-43836-7_4
Laskowitz DT, Bennett ER, Durham RJ, Volpi JJ, Wiese JR, Frankel M, Shpall E, Wilson JM, Troy J, Kurtzberg J (2018) Allogeneic umbilical cord blood infusion for adults with ischemic stroke: Clinical outcomes from a phase 1 safety study. Stem Cells Transl Med 7:521–529. doi: 10.1002/sctm.18-0008
Lee S, Sohn Y, Choi Y, Park N, Yoon H (2010) Culture of mesenchymal stromal cells from dental pulp: Culture medium study for effective expansion and characterization. Tissue Eng Regen Med 7:248–254
Li Z, Niu S, Guo B, Gao T, Wang L, Wang Y, Wang L, Tan Y, Wu J, Hao J (2020) Stem cell therapy for COVID-19, ARDS and pulmonary fibrosis. Cell Prolif 53:e12939. doi: 10.1111/cpr.12939
Lin HT, Tarng YW, Chen YC, Kao CL, Hsu CJ, Shyr YM, Ku HH, Chiou SH (2005) Using human plasma supplemented medium to cultivate human bone marrow-derived mesenchymal stem cell and evaluation of its multiple-lineage potential. Transplant Proc 37:4504–4505. doi: 10.1016/j.transproceed.2005.11.033
Liu D, Cheng F, Pan S, Liu Z (2020) Stem cells: A potential treatment option for kidney diseases. Stem Cell Res Ther 11:249. doi: 10.1186/s13287-020-01751-2
Kos MJ, Skubis A, Ghavami S (2019) Stem cells. Pp 5–16. In: Kos MJ, Hudecki A, Wiechec E (Eds). Stem Cells and Biomaterials for Regenerative Medicine. Elsevier Inc. doi: 10.1016/B978-0-12-812258-7.00002-2
Macrin D, Joseph JP, Pillai A, Devi A (2017) Eminent sources of adult mesenchymal stem cells and their therapeutic imminence. Stem Cell Rev Rep 13:741–756. doi: 10.1007/s12015-017-9759-8
Matthyssen S, Ní Dhubhghaill S, Van Gerwen V, Zakaria N (2017) Xeno-free cultivation of mesenchymal stem cells from the corneal stroma. Invest Ophthalmol Vis Sci 58:2659–2665. doi: 10.1167/iovs.17-21676
Mirabet V, Solves P, Minana D, Encabo A, Carbonell-Uberos F, Blanquer A, Roig R (2008) Human platelet lysate enhances the proliferative activity of cultured human fibroblast-like cells from different tissues. Cell Tissue Bank 9:1–10. doi: 10.1007/s10561-007-9048-x
Mojica-Henshaw MP, Jacobson P, Morris J, Kelley L, Pierce J, Boyer M, Reems JA (2013) Serum-converted platelet lysate can substitute for fetal bovine serum in human mesenchymal stromal cell cultures. Cytotherapy 15:1458–1468. doi: 10.1016/j.jcyt.2013.06.014
Naaijkens BA, Niessen HWM, Prins HJ, Krijnen PAJ, Kokhuis TJA, de Jong N, van Hinsbergh VWM, Kamp O, Helder MN, Musters RJP, van Dijk A, Juffermans LJM (2012) Human platelet lysate as a fetal bovine serum substitute improves human adipose-derived stromal cell culture for future cardiac repair applications. Cell Tissue Res 348:119–130. doi: 10.1007/s00441-012-1360-5
Oikonomopoulos A, van Deen WK, Manansala A-R, Lacey PN, Tomakili TA, Ziman A, Hommes DW (2015) Optimization of human mesenchymal stem cell manufacturing: The effects of animal/xeno-free media. Sci Rep 5:16570. doi: 10.1038/srep16570
Van Pham P, Vu NB (2016) In vitro expansion of mesenchymal stem cells for clinical use. Prog Stem Cell 3:87–96. doi: 10.15419/psc.v3i02.123
Rantam F, Ferdiansyah, Nasronudin, Purwati (2009) Stem cell exploration - Method of isolation and culture. 1st Edition. Airlangga University Press, Surabaya
Sagaradze G, Grigorieva O, Nimiritsky P, Basalova N, Kalinina N, Akopyan Z, Efimenko A (2019) Conditioned medium from human mesenchymal stromal cells: Towards the clinical translation. Int J Mol Sci 20:1656. doi: 10.3390/ijms20071656
Salzig D, Schmiermund A, Grace PP, Elseberg C, Weber C, Czermak P (2013) Enzymatic detachment of therapeutic mesenchymal stromal cells grown on glass carriers in a bioreactor. Open Biomed Eng J 7:147–158. doi: 10.2174/1874120701307010147
Santos SC, Sigurjonsson ÓE, Custódio CA, Mano J (2018) Blood plasma derivatives for tissue engineering and regenerative medicine therapies. Tissue Eng Part B Rev 24:454–462. doi: 10.1089/ten.TEB.2018.0008.Blood
Suryani D, Pawitan JA, Lilianty J, Purwoko RY, Liem IK, Damayanti L (2013) Comparison of fetal bovine serum and platelet-rich plasma on human lipoaspirate-derived mesenchymal stem cell proliferation. Med J Indones 22:146–51. doi: 10.13181/mji.v22i3.583
Tavakolinejad S, Khosravi M, Mashkani B, Bideskan AE, Mossavi NS, Parizadeh SMR, Alamdari DH (2014) The effect of human platelet-rich plasma on adipose-derived stem cell proliferation and osteogenic differentiation. Iran Biomed J 18:151–157. doi: 10.6091/ibj.1301.2014
Teixeira FG, Carvalho MM, Sousa N, Salgado AJ (2013) Mesenchymal stem cells secretome: A new paradigm for central nervous system regeneration? Cell Mol Life Sci 70:3871–3882. doi: 10.1007/s00018-013-1290-8
van der Valk J, Bieback K, Buta C, Cochrane B, Dirks WG, Fu J,Hickman JJ, Hohensee C, Kolar R, Liebsh M, Pistollato F, Schulz M, Thieme D, Weber T, Wiest J, Winkler S, Gstraunthaler G (2018) Fetal Bovine Serum (FBS): Past – Present – Future. ALTEX 35:99–118. doi: 10.14573/altex.1705101
Wang X, Zheng F, Liu O, Zheng S, Liu Y, Wang Y, Tang Z, Zhong L (2013) Epidermal growth factor can optimize a serum-free culture system for bone marrow stem cell proliferation in a miniature pig model. In Vitro Cell Dev Biol Anim 49:815–825. doi: 10.1007/s11626-013-9665-6
Yoshida K, Nakashima A, Doi S, Ueno T, Okubo T, Kawano KI, Kanawa M, Kato Y, Higashi Y, Masaki T (2018) Serum-free medium enhances the immunosuppressive and antifibrotic abilities of mesenchymal stem cells utilized in experimental renal fibrosis. Stem Cells Transl Med 7:893–905. doi: 10.1002/sctm.17-0284
Zakrzewski W, Dobrzynski M, Szymonowicz M, Rybak Z (2019) Stem cells: past, present, and future. Stem Cell Res Ther 10:68. doi: 10.1186/s13287-019-1165-5